Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib trial of SYN 004 in healthy volunteers as a potential therapy for the prevention of Clostridium difficile infection, antibacterial-associated diarrhoea and secondary antibacterial-resistant infections in patients receiving intravenous beta-lactam antibacterial therapy

Next Previous
Search
Trial Profile

Phase Ib trial of SYN 004 in healthy volunteers as a potential therapy for the prevention of Clostridium difficile infection, antibacterial-associated diarrhoea and secondary antibacterial-resistant infections in patients receiving intravenous beta-lactam antibacterial therapy

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ribaxamase (Primary)
  • Indications Bacterial infections; Clostridium difficile infections; Diarrhoea
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Synthetic Biologics

    • Most Recent Events

    • 09 Jun 2016 Results of two phase I studies published in the Clinical Drug Investigation.
    • 19 Nov 2015 According to a Synthetic Biologics media release, clinical updates from this trial will be presented at the Microbiome Clinical Program Seminar to be hosted by the company on December 10, 2015.
    • 03 Jun 2015 According to a Synthetic Biologics media release, data from this study were presented at the 115th General Meeting of the American Society of Microbiology (ASM2015).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top